Work

Comprehensive Biomarker Strategy to Monitor GNTI-122, an Engineered Regulatory T Cell Therapy in Clinical Development to Treat Type 1 Diabetes 2252996

Year: 2026

Type: article

Source: The Journal of Immunology

DOI: 10.1093/jimmun/vkag141.150

Authors: Gene Uenishi, Dalia Gaddis, Marko Repic, Jennifer Yam, Ethan McClain, Ritika Tewari, Clara Domingo Vila, Timothy Tree, Karen Cerosaletti, Tom Wickham, Chandra Patel, Mark Bach

Institutions: GentiBio (United States), Benaroya Research Institute, King's College London

Language: English

Topic: Diabetes and associated disorders

Subfield: Genetics

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7171486871

FWCI:

Cites:

Cited by:

Related to: